Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7726225rdf:typepubmed:Citationlld:pubmed
pubmed-article:7726225lifeskim:mentionsumls-concept:C1845055lld:lifeskim
pubmed-article:7726225lifeskim:mentionsumls-concept:C0205488lld:lifeskim
pubmed-article:7726225lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:7726225lifeskim:mentionsumls-concept:C1879746lld:lifeskim
pubmed-article:7726225lifeskim:mentionsumls-concept:C1547011lld:lifeskim
pubmed-article:7726225pubmed:issue3lld:pubmed
pubmed-article:7726225pubmed:dateCreated1995-5-25lld:pubmed
pubmed-article:7726225pubmed:abstractTextThe hallmarks of the X-linked alpha-thalassemia/mental retardation (ATR-X) syndrome are severe psychomotor retardation, minor facial anomalies, genital abnormalities, and an unusual form of alpha-thalassemia. The demonstration of HbH inclusions in red blood cells after incubation with brilliant cresyl blue confirms the diagnosis. We describe 15 previously unreported cases and analyse the phenotypic and hematologic findings in these subjects and compare them with previously published cases. This study demonstrates the consistency of the main characteristics of this syndrome and extends the phenotype. Developmental changes in phenotype, in particular the coarsening of the facial appearance, are illustrated. The hematologic findings are shown to vary widely; in some cases the manifestation of alpha-thalassemia may be subtle and missed without repeated examination.lld:pubmed
pubmed-article:7726225pubmed:languageenglld:pubmed
pubmed-article:7726225pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7726225pubmed:citationSubsetIMlld:pubmed
pubmed-article:7726225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7726225pubmed:statusMEDLINElld:pubmed
pubmed-article:7726225pubmed:monthJanlld:pubmed
pubmed-article:7726225pubmed:issn0148-7299lld:pubmed
pubmed-article:7726225pubmed:authorpubmed-author:GibbonsR JRJlld:pubmed
pubmed-article:7726225pubmed:authorpubmed-author:GardnerR JRJlld:pubmed
pubmed-article:7726225pubmed:authorpubmed-author:BurgMMlld:pubmed
pubmed-article:7726225pubmed:authorpubmed-author:BuckleV JVJlld:pubmed
pubmed-article:7726225pubmed:authorpubmed-author:KearneyLLlld:pubmed
pubmed-article:7726225pubmed:authorpubmed-author:KingstonH MHMlld:pubmed
pubmed-article:7726225pubmed:authorpubmed-author:Clayton-Smith...lld:pubmed
pubmed-article:7726225pubmed:authorpubmed-author:DavisonB CBClld:pubmed
pubmed-article:7726225pubmed:authorpubmed-author:BruetonLLlld:pubmed
pubmed-article:7726225pubmed:authorpubmed-author:HomfrayTTlld:pubmed
pubmed-article:7726225pubmed:issnTypePrintlld:pubmed
pubmed-article:7726225pubmed:day30lld:pubmed
pubmed-article:7726225pubmed:volume55lld:pubmed
pubmed-article:7726225pubmed:ownerNLMlld:pubmed
pubmed-article:7726225pubmed:authorsCompleteNlld:pubmed
pubmed-article:7726225pubmed:pagination288-99lld:pubmed
pubmed-article:7726225pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:7726225pubmed:meshHeadingpubmed-meshheading:7726225-...lld:pubmed
pubmed-article:7726225pubmed:meshHeadingpubmed-meshheading:7726225-...lld:pubmed
pubmed-article:7726225pubmed:meshHeadingpubmed-meshheading:7726225-...lld:pubmed
pubmed-article:7726225pubmed:meshHeadingpubmed-meshheading:7726225-...lld:pubmed
pubmed-article:7726225pubmed:meshHeadingpubmed-meshheading:7726225-...lld:pubmed
pubmed-article:7726225pubmed:meshHeadingpubmed-meshheading:7726225-...lld:pubmed
pubmed-article:7726225pubmed:meshHeadingpubmed-meshheading:7726225-...lld:pubmed
pubmed-article:7726225pubmed:meshHeadingpubmed-meshheading:7726225-...lld:pubmed
pubmed-article:7726225pubmed:meshHeadingpubmed-meshheading:7726225-...lld:pubmed
pubmed-article:7726225pubmed:meshHeadingpubmed-meshheading:7726225-...lld:pubmed
pubmed-article:7726225pubmed:meshHeadingpubmed-meshheading:7726225-...lld:pubmed
pubmed-article:7726225pubmed:meshHeadingpubmed-meshheading:7726225-...lld:pubmed
pubmed-article:7726225pubmed:meshHeadingpubmed-meshheading:7726225-...lld:pubmed
pubmed-article:7726225pubmed:meshHeadingpubmed-meshheading:7726225-...lld:pubmed
pubmed-article:7726225pubmed:meshHeadingpubmed-meshheading:7726225-...lld:pubmed
pubmed-article:7726225pubmed:meshHeadingpubmed-meshheading:7726225-...lld:pubmed
pubmed-article:7726225pubmed:meshHeadingpubmed-meshheading:7726225-...lld:pubmed
pubmed-article:7726225pubmed:meshHeadingpubmed-meshheading:7726225-...lld:pubmed
pubmed-article:7726225pubmed:year1995lld:pubmed
pubmed-article:7726225pubmed:articleTitleClinical and hematologic aspects of the X-linked alpha-thalassemia/mental retardation syndrome (ATR-X).lld:pubmed
pubmed-article:7726225pubmed:affiliationMRC Molecular Haematology Unit, John Radcliffe Hospital, Headington, Oxford, United Kingdom.lld:pubmed
pubmed-article:7726225pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7726225pubmed:publicationTypeReviewlld:pubmed
pubmed-article:7726225pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:7726225pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7726225lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7726225lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7726225lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7726225lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7726225lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7726225lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7726225lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7726225lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7726225lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7726225lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7726225lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7726225lld:pubmed